We keep you updated

The U.S. Department of Justice has allowed the sale of the Americas operating unit, which comprises the American salt business of K+S Aktiengesellschaft, to Stone Canyon Industries Holdings LLC, Mark Demetree and Partners to proceed.

The US Department of Justice has allowed the sale of the American salt business to Stone Canyon Industries in the USA to proceed.

K+S is pleased with the initiative of the Lower Saxony supervisory authority in addressing open issues concerning approval procedures for the Lower Saxony-Riedel mine and the tailings pile in Wathlingen, and finding a target-oriented solution accordingly.

Through extensive prevention measures and an effectively functioning crisis management system, K+S has been mastering the challenges of the ongoing corona pandemic comparatively well. The company posts operating earnings EBITDA of €445 million (2019: €640 million), including discontinued operations.

The Supervisory Board of K+S Aktiengesellschaft has appointed Mr. Holger Riemensperger (51) to the Board of Executive Directors of the Company. As of April 1, 2021, he will assume responsibility as Chief Operating Officer (COO) for the management and further development of the Agriculture and Industry+ customer segments, and the Production and Engineering, Supply Chain as well as Health, Safety, Sustainability, Quality & Management System functions at K+S.

Following the presentation of the consolidated financial statements as of December 31, 2020 by the Board of Executive Directors, the Company's auditor, Deloitte GmbH Wirtschaftsprüfungsgesellschaft, Hanover, today issued an unqualified audit opinion on the 2020 consolidated financial statements.

At the occasion-related request of the German Federal Financial Supervisory Authority ("Bundesanstalt für Finanzdienstleistungsaufsicht - BaFin"), the German Audit Office for Accounting ("Deutsche Prüfstelle für Rechnungslegungsaufsicht - DPR") examines the consolidated financial statements of K+S Aktiengesellschaft ("K+S") as of December 31, 2019, together with the related interim group management report and the abbreviated financial statements as of June 30, 2020.

At the beginning of November last year, K+S announced to the public that the Board of Executive Directors had adjusted its long-term assumptions for the potash business. Essentially, this related to the long-term development of potash prices. Furthermore, an adjustment of the weighted average cost of capital (WACC) became mandatory. Overall, this resulted in a non-cash, one-off impairment loss of around €2 billion on assets in the Europe+ operating unit.

K+S has noted that the price agreed for potash supplies is significantly below the level currently prevailing on important export markets. Therefore, the continuing positive fundamental situation of the agricultural markets as well as the associated increasing demand for potash fertilizers is not reflected in any way.

The Biontech/Pfizer corona vaccine COMIRNATY® is only applicable with the addition of high-purity sodium chloride solution. K+S is one of the largest manufacturers of the pharmaceutical-grade sodium chloride required for this purpose.